Jiao Jin

Guiyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Long-term outcomes with emicizumab prophylaxis for haemophilia A in China: A multicentre, large-cohort retrospective study.

Long-term outcomes with emicizumab prophylaxis for haemophilia A in China: A multicentre, large-cohort retrospective study.

Journal: British journal of haematology
Published: January 20, 2026

Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023.

Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023.

Journal: Cancer
Published: October 28, 2025

Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial.

Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial.

Journal: Research and practice in thrombosis and haemostasis
Published: July 21, 2024

Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.

Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.

Journal: EClinicalMedicine
Published: February 26, 2024

Clinical analysis and quality of life survey of hemophilia B patients in the central and western regions of China.

Clinical analysis and quality of life survey of hemophilia B patients in the central and western regions of China.

Journal: Frontiers in pediatrics
Published: January 08, 2024

Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study.

Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 02, 2023

Molecular Characterization of α- and β-Thalassemia Among Children Less Than 18 Years Old in Guizhou, China.

Molecular Characterization of α- and β-Thalassemia Among Children Less Than 18 Years Old in Guizhou, China.

Journal: Journal of clinical laboratory analysis
Published: July 26, 2023

Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses.

Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses.

Journal: Hematology (Amsterdam, Netherlands)
Published: July 18, 2023

A cohort study of vincristine-induced peripheral neuropathy in children

A cohort study of vincristine-induced peripheral neuropathy in children

Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: June 05, 2023

Circular RNA circ_0040823 inhibits the proliferation of acute myeloid leukemia cells and induces apoptosis by regulating miR-516b/PTEN.

Circular RNA circ_0040823 inhibits the proliferation of acute myeloid leukemia cells and induces apoptosis by regulating miR-516b/PTEN.

Journal: The journal of gene medicine
Published: October 08, 2021

Inhibition of P38 MAPK Downregulates the Expression of IL-1β to Protect Lung from Acute Injury in Intestinal Ischemia Reperfusion Rats.

Inhibition of P38 MAPK Downregulates the Expression of IL-1β to Protect Lung from Acute Injury in Intestinal Ischemia Reperfusion Rats.

Journal: Mediators of inflammation
Published: September 21, 2015
Showing 1-11 of 11

Last Updated: 09/26/2026